ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada · Delayed Price · Currency is CAD 0.4950
+0.0450 (10.00%)
At close: May 6, 2026
ZYUS Life Sciences Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| -0.11 | 0 | 0 | 0.35 | 0.3 | - | |
Revenue Growth | - | -15.80% | -99.86% | 17.79% | 120547.77% | - |
Cost of Revenue | 0.24 | 0.22 | 0.21 | 0.15 | 0.1 | - |
Gross Profit | 0.05 | 0.05 | 0.13 | 0.17 | -0.23 | - |
Selling, General & Admin | 7.42 | 7.74 | 8.67 | 12.01 | 8.68 | - |
Depreciation & Amortization Expenses | -0.52 | 0 | 0 | 3.11 | 4.05 | - |
Research & Development | 2.64 | 2.86 | 2.05 | 1.31 | 2.21 | - |
Other Operating Expenses | 0.96 | 5.78 | 21.59 | 27.88 | 4.05 | - |
Total Operating Expenses | 10.5 | 16.38 | 32.31 | 44.31 | 18.99 | 0 |
Operating Income | -17.77 | -18.91 | -34.99 | -42.14 | -18.79 | -0.23 |
Interest Income | 0.46 | - | - | - | - | 0.58 |
Interest Expense | -3.12 | -2.87 | -1.08 | -3.85 | -5.46 | - |
Other Non-Operating Income (Expense) | -0.6 | -0 | -0.35 | -1.9 | -6.81 | - |
Total Non-Operating Income (Expense) | -3.26 | -2.88 | -1.43 | -5.74 | -12.28 | 0.58 |
Pretax Income | -20.83 | -21.73 | -35.89 | -48.44 | -24.72 | 0.35 |
Provision for Income Taxes | - | - | -2.09 | -5.85 | -0.06 | - |
Net Income | -20.83 | -21.73 | -33.81 | -42.59 | -24.66 | 0.35 |
Net Income to Common | -20.83 | -21.73 | -33.81 | -42.59 | -24.66 | 0.35 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 78 | 77 | 72 | 56 | 38 | 5 |
Shares Outstanding (Diluted) | 78 | 77 | 72 | 56 | 38 | 5 |
Shares Change | 7.27% | 6.59% | 28.41% | 45.82% | 665.26% | - |
EPS (Basic) | -0.27 | -0.28 | -0.47 | -0.76 | -0.64 | 0.07 |
EPS (Diluted) | -0.27 | -0.28 | -0.47 | -0.76 | -0.64 | 0.07 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.79 | -9.24 | -9.92 | -18.23 | -10.13 | -0.33 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.10 | -0.12 | -0.14 | -0.32 | -0.26 | -0.07 |
Gross Margin | -39.66% | 12345.70% | 26819.10% | 48.72% | -77.85% | - |
Operating Margin | 15661.00% | -4669630.00% | -7274840.00% | -12006.00% | -6306.04% | - |
Profit Margin | 18360.30% | -5365680.00% | -7028070.00% | -12134.20% | -8274.16% | - |
FCF Margin | 6865.07% | -2281730.00% | -2062790.00% | -5193.45% | -3400.67% | - |
EBITDA | -18.29 | -18.91 | -34.99 | -39.04 | -14.75 | -0.23 |
EBITDA Margin | 16117.70% | -4668960.00% | -7274230.00% | -11121.10% | -4948.66% | - |
EBIT | -17.77 | -18.91 | -34.99 | -42.14 | -18.79 | -0.23 |
EBIT Margin | 15661.00% | -4669630.00% | -7274840.00% | -12006.00% | -6306.04% | - |
Effective Tax Rate | - | 0.00% | 5.82% | 12.07% | 0.23% | 0.00% |